**Core Concept:** RET gene mutation is a genetic defect that can lead to the development of certain types of cancer. The RET gene is a proto-oncogene that, when mutated, can cause dysregulation of cell growth and differentiation, leading to uncontrolled cell division and the formation of tumors. In this case, the RET gene mutation is associated with malignancies.

**Why the Correct Answer is Right:** The correct answer, **Option C**, refers to the RET gene mutation being associated with medullary thyroid carcinoma (MTC). MTC is a type of thyroid cancer that originates from the parafollicular cells, which produce calcitonin. RET gene mutations, especially those in exons 10, 11, 13, and 14, are the most common genetic causes of MTC. These mutations lead to constitutive activation of the RET protein, causing uncontrolled cell growth and tumor development.

**Why Each Wrong Option is Incorrect:**

**Option A (Leukemia):** While RET gene mutations have been implicated in certain types of leukemia, such as B-cell acute lymphoblastic leukemia (B-ALL), they are not specifically associated with the malignancy mentioned in the question.

**Option B (Colorectal Cancer):** RET gene mutations are not a primary cause of colorectal cancer (CRC). While they may be found in advanced CRC cases, they are more commonly associated with MTC and other neuroendocrine tumors (NETs).

**Option D (Lymphoma):** RET gene mutations are not exclusively linked to lymphoma. While they can be found in certain types of lymphoma, they are not the primary cause of the malignancy mentioned in the question.

**Clinical Pearl:** RET gene mutations can be found in various cancers, but the correct answer (Option C, medullary thyroid carcinoma) is specifically associated with RET gene mutations due to their role in dysregulating cell growth and differentiation, leading to tumor development. Understanding RET gene mutations and their implications in cancer can help in diagnosing and treating patients with related cancers, including MTC.